Subchronic oral exposure of dogs to Oxodipine, a new calcium channel blocker of the dihydropyridine-type, resulted in dose-related gingival hyperplastic changes. The doses at which an effect was elicited were 24 and 73 times the intended therapeutic dose for man. The effeçts were first noted after 7 weeks of treatment, and were limited to the high and intermediate dose groups of both sexes. Macroscopically, a generalized enlargement of the maxillary and mandibular facial and lingual gingivae were noted. The histological changes were similar to those described in man for Nifedipine and hydantoin-related drugs. An increase in the activity of alkaline phosphatase and a decrease in alanine aminotransferase was demonstrated. This article is the first to describe gingival hyperplasia in dogs induced in a dose-dependent manner by a calcium channel blocker.
References
1.
1. Bencini PL, Crosti C, Sala F, Ambroso GC, and Marini DG (1986). Gingival hyperplasia due to Nifedipine. Ital. Dermatol. Venereol.121: 29–31.
2.
2. Bunch SE, Castleman WL, Hornbuckle WE, and Tennant BC (1982). Hepatic cirrhosis associated with long-term anticonvulsant drug therapy in dogs. JAVMA181: 357–362.
3.
3. Carrel R, Ba TT, and Chapman MK (1983). Gingival aberrations in dilantin treated guinea pigs. J. Pedod.7: 229–240.
4.
4. Dhami MSI, Drangova R, Farkas R, Balazs T, and Feuer G (1979). Decreased aminotransferase activity of serum and various tissues in the rat after Cefazolin treatment. Clin. Chem.25: 1263–1266.
5.
5. do-Nascimento A, Barreto R-de-C, Bozzo L, and de-Almeida OP (1985). Interaction of phenytoin and inflammation induces gingival overgrowth in rats. J. Periodont. Res.20: 386–391.
6.
6. Fonseca I, Martinez Carrera S, and Garcia-Blanco S (1986). Structure of Oxodipine: New calcium antagonist. Acta Crystallogr.42: 1792–1794.
7.
7. Galiano A (1987). Personal communication.
8.
8. Greeley S and Sanstead HH (1983). Oxidation of alanine B-hydroxybutynate in late gestation in zinc-restricted rats. J. Nutr.113: 1803–1810.
9.
9. Hall BK and Squier CA (1982). Ultrastructural quantification of connective tissue changes in phenytoin-induced gingival overgrowth in the ferret. J. Dent. Res.61: 942–952.
10.
10. Hassel TM and Page RC (1978). The major metabolite of phenytoin (dilantin) induces gingival overgrowth in cats. J. Periodont. Res.13: 280–282.
11.
11. Hassel TM, Page RC, Narayanan AS, and Cooper CG (1976). Diphenylhydantoin (dilantin) gingival hyperplasia: Drug induced abnormality of connective tissue. Proc. Natl. Acad. Sci. USA73: 2909–2912.
12.
12. Hassell TM, Roebuck S, Page RC, and Wray SH (1982). Quantitative histopathologic assessment of developing phenytoin-induced gingival overgrowth in the cat. J. Clin. Periodont.9: 365–372.
13.
13. Jezyk PF, Haskins ME, MacKay-Smith WE, and Patterson DF (1986). Lethal acrodermatitis in bull terriers.JAVMA188(8): 833–839.
14.
14. Kantor MI and Hasel TM (1983). Increased accumulation of sulfated glycosaminoglycans in cultures of human fibroblasts from phenytoin-induced gingival overgrowth.J. Dent. Res.62: 383.
15.
15. Kimball OP (1939). The treatment of epilepsy with sodium-diphenylhydantoin. J. Am. Med. Assoc.112: 1244–1245.
16.
16. Latimer KS, Rakich PM, Purswell BJ, and Kircher IM (1986). Effects of cyclosporin A administration in cats. Vet. Immunol. Immunopathol.11: 161–173.
17.
17. Lederman D, Lumerman H, Reuben S, and Freedman PD (1984). Gingival hyperplasia associated with Nifedipine therapy. Oral Surg.57: 620–622.
18.
18. Lucas RM, Howell LP, and Wall BA (1985). Nifedipine-induced gingival hyperplasia: A histochemical and ultrastructural study. J. Periodontol.56: 211–215.
19.
19. Mantel N (1963). Chi-square tests with one degree of freedom; extensions of the Mantel-Haenszel procedure. J. Am. Stat. Assoc.58: 690–700.
20.
20. Moore PA, Smudski JW, and Hopper S (1979). Diphenylhydantoin induced gingival hyperplasia in ferrets: A precautionary note. J. Dent. Res.58: 1812–1814.
21.
21. Ramon Y, Behar S, Kishon Y, and Engelberg IS (1984). Gingival hyperplasia caused by Nifedipine–-A preliminary report. Int. J. Cardiol.5: 195–204.
22.
22. Rateitschak-Pluss EM, Hefti A, Lortscher R, and Theil G (1983). Initial observations that cyclosporin-A induces gingival enlargement in man. Clin. Periodont. Res.10: 237–246.
23.
23. Rost DR and Baker R (1978). Gingival hyperplasia induced by sodium diphenylhydantoin in the dog: A case report. Vet. Med.73: 585–587.
24.
24. Syrjamen SM and Syrjamen KJ (1979). Hyperplastic gingivitis in a child receiving sodium valporate treatment. Proc. Finn. Dent. Soc.75: 95–98.
